Ann: Quarterly Activities Report and Appendix 4C, page-2

This is all we need to see...sound like most participants are continuing and no participant have withdrawn from the ...which is massive positive ...

Rest is all the activities we all know about ..


As at 30 September 2024, thirty four patients had completed participation in the blinded phase of the trial, comprising the first six months of treatment. Of these, three had
completed all activities associated with trial participation, while the remainder
continued in either the open-label phase of the study, comprising the second six months
of treatment, or the four-month off-treatment follow-up period. To date, no patient has
withdrawn from the trial prior to full completion.

Glh...